Hickey v. Hospira makes the list of “top food and drug cases” in 2024 because the Fifth Circuit recognized that implied preemption applies with equal force to drugs entering the market under the Section 505(b)(2) process as would apply to those coming to market under the more onerous New Drug Application process of Section 505(b)(1).
LINKS
Read “Hickey v. Hospira, Inc.,” authored by Ginger Pigott in Food & Drug Law Institute's “Top Food and Drug Cases, 2024.”
PDF shared with the permission of FDLI.